ReviewJournal of diabetes and metabolic disorders2025
Non-blood type O is associated with an increased likelihood of gestational diabetes development: findings from an updated meta-analysis.
Review in Journal of diabetes and metabolic disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Several factors are attributed to the development of gestational diabetes mellitus (GDM), but its association with the ABO blood group is still unexplored. Hence, we performed a meta-analysis to examine this association. Methods: Relevant articles were obtained from various databases until April 5, 2025. All related data were extracted by two authors and summarized in a customized spreadsheet. Odds ratios (ORs) and 95% confidence intervals (CIs) were computed and interpreted. Results: The pooled analysis showed homogeneity in the outcomes. Pooled ORs show that pregnant women with non-blood type O showed more significant associations than those with blood type O. Conclusion: Overall, the present meta-analysis suggests that individuals with non-blood type O have an increased risk of developing GDM compared to those with blood type O. However, further studies stratifying populations based on insulin resistance, gut microbiota, and inflammation in association with ABO and GDM development are needed to confirm these claims. Supplementary Information: The online version contains supplementary material available at 10.1007/s40200-025-01653-1.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.